It is not a GLP-1 receptor agonist, a weight-loss drug, or a substitute for any prescribed medication, and it is not intended to treat obesity, diabetes, or any other condition
Tirzepatide demonstrates significant extrahepatic benefits beyond its well-established hepatic effects, particularly in the cardiovascular and metabolic domains
Yes, increased GLP-1 activity can support GLP-1 weight loss by improving satiety signals, reducing hunger, and helping people eat smaller portions
Use outside of clinical trials is illegal in many jurisdictions
Tirzepatide (GLP-1 + GIP Support) Weekly in-office injections: from $69 per visit Monthly program: from $279 10-week program: from $449 20-week program: from $749 Semaglutide (GLP-1 Support) Weekly in-office injections: from $69 per visit Monthly program: from $179 3-month program: from $399 Whats Included Provider-guided treatment Customized dosing based on your medical profile Telehealth and in-office options available Important Information Pricing may vary based on dosage, treatment plan, and individual medical needs
Among these, tirzepatide demonstrated the greatest efficacy in lowering both HbA1c and fasting glucose levels
